Here is a breakdown of major shareholders in 2seventy bio Inc (NASDAQ: TSVT)

2seventy bio Inc (NASDAQ: TSVT) is 40.28% higher on its value in year-to-date trading and has touched a low of $1.53 and a high of $14.41 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TSVT stock was last observed hovering at around $5.59 in the last trading session, with the day’s gains setting it 0.4%.

Currently trading at $5.99, the stock is 48.74% and 67.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing 7.16% at the moment leaves the stock -3.10% off its SMA200. TSVT registered -56.88% loss for a year compared to 6-month loss of 2.92%. The firm has a 50-day simple moving average (SMA 50) of $2.14 and a 200-day simple moving average (SMA200) of -$1.79.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 43.99% gain in the last 1 month and extending the period to 3 months gives it a 135.83%, and is 15.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.18% over the week and 12.68% over the month.

2seventy bio Inc (TSVT) has around 425 employees, a market worth around $303.21M and $145.88M in sales. Profit margin for the company is -126.06%. Distance from 52-week low is 290.23% and -58.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.17%).

2seventy bio Inc quarterly earnings per share for the current quarter are estimated at -$0.99 with sales reaching $14.78M over the same period.The EPS is expected to grow by 38.78% this year, but quarterly earnings will post 15.20% year-over-year. Quarterly sales are estimated to shrink -73.70% in year-over-year returns.

199 institutions hold shares in 2seventy bio Inc (TSVT), with institutional investors hold 104.91% of the company’s shares. The shares outstanding are 50.62M, and float is at 46.65M with Short Float at 13.72%. Institutions hold 102.71% of the Float.

The top institutional shareholder in the company is Kynam Capital Management, LP with over 4.89 million shares valued at $49.49 million. The investor’s holdings represent 9.69% of the TSVT Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 4.14 million shares valued at $41.85 million to account for 8.19% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.48 million shares representing 6.89% and valued at over $35.19 million, while State Street Corporation holds 6.06% of the shares totaling 3.06 million with a market value of $30.97 million.

2seventy bio Inc (TSVT) Insider Activity

A total of 15 insider transactions have happened at 2seventy bio Inc (TSVT) in the last six months, with sales accounting for 3 and purchases happening 12 times. The most recent transaction is an insider sale by Leschly Nick, the company’s President and CEO. SEC filings show that Leschly Nick sold 1,554 shares of the company’s common stock on Jan 05 at a price of $3.75 per share for a total of $5833.0. Following the sale, the insider now owns 1.09 million shares.

2seventy bio Inc disclosed in a document filed with the SEC on Jan 05 that Baird William D III (Chief Operating Officer) sold a total of 1,380 shares of the company’s common stock. The trade occurred on Jan 05 and was made at $3.75 per share for $5180.0. Following the transaction, the insider now directly holds 0.16 million shares of the TSVT stock.

Still, SEC filings show that on Jan 05, Gregory Philip D (Chief Scientific Officer) disposed off 795 shares at an average price of $3.75 for $2984.0. The insider now directly holds 230,842 shares of 2seventy bio Inc (TSVT).